EYPT vs IVZ · rev $1.2M vs rev $3.57B
Eyepoint Pharmaceuticals Inc (EYPT) versus Invesco Plc (IVZ) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
EYPT currently screens at market cap $1.10B. IVZ currently screens at market cap $12.76B.
Not investment advice. Open the EYPT and IVZ stock pages for the full models.
Not investment advice.